4.3 Review

Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

Chris Twelves et al.

Summary: The study found that with personalized dosing, nabiximols demonstrated acceptable safety and tolerability with no drug-drug interactions identified. The observed survival differences support further exploration in a well-powered randomized controlled trial.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Medicine, General & Internal

Striking lung cancer response to self-administration of cannabidiol: A case report and literature review

Josep Sule-Suso et al.

SAGE OPEN MEDICAL CASE REPORTS (2019)

Article Obstetrics & Gynecology

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma

Allison M. Barrie et al.

GYNECOLOGIC ONCOLOGY REPORTS (2019)

Review Pharmacology & Pharmacy

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents

Daniel A. Ladin et al.

FRONTIERS IN PHARMACOLOGY (2016)